Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents
- DOI
- 10.1158/2643-3230.bcd-25-0193
- Published
- 2026-02-11
- Container
- Blood Cancer Discovery
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/2643-3230.bcd-25-0193,
title = {Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents},
author = {Dimitrios Drekolias and Fatima Tuz Zahra and Caroline Fileni and David A. Sallman and Qianxing Mo and Onyee Chan and Ling Zhang and Nicole D. Vincelette and Xiaoqing Yu and Rinzine Sammut and Jungwon Moon and Junyoung Park and Sura-Attha Umasangtongkul and Felyschia M. Lledo and Tiffany N. Razabdouski and Chia-Ho Cheng and Dahui Qin and Kathy Mai and Somedeb Ball and Rory M. Shallis and Zhuoer Xie and Andrew T. Kuykendall and Eric Padron and Kendra Sweet and Alison R. Walker and Rami S. Komrokji and Jeffrey E. Lancet and Sandrine Niyongere and Thomas Cluzeau and Seongseok Yun},
year = {2026},
journal = {Blood Cancer Discovery},
doi = {10.1158/2643-3230.bcd-25-0193},
url = {https://doi.org/10.1158/2643-3230.bcd-25-0193}
}RIS
TY - JOUR TI - Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents AU - Dimitrios Drekolias AU - Fatima Tuz Zahra AU - Caroline Fileni AU - David A. Sallman AU - Qianxing Mo AU - Onyee Chan AU - Ling Zhang AU - Nicole D. Vincelette AU - Xiaoqing Yu AU - Rinzine Sammut AU - Jungwon Moon AU - Junyoung Park AU - Sura-Attha Umasangtongkul AU - Felyschia M. Lledo AU - Tiffany N. Razabdouski AU - Chia-Ho Cheng AU - Dahui Qin AU - Kathy Mai AU - Somedeb Ball AU - Rory M. Shallis AU - Zhuoer Xie AU - Andrew T. Kuykendall AU - Eric Padron AU - Kendra Sweet AU - Alison R. Walker AU - Rami S. Komrokji AU - Jeffrey E. Lancet AU - Sandrine Niyongere AU - Thomas Cluzeau AU - Seongseok Yun PY - 2026 JO - Blood Cancer Discovery DO - 10.1158/2643-3230.bcd-25-0193 UR - https://doi.org/10.1158/2643-3230.bcd-25-0193 ER -
APA
Drekolias, D., Zahra, F. T., Fileni, C., Sallman, D. A., Mo, Q., Chan, O., Zhang, L., Vincelette, N. D., Yu, X., Sammut, R., Moon, J., Park, J., Umasangtongkul, S., Lledo, F. M., Razabdouski, T. N., Cheng, C., Qin, D., Mai, K., Ball, S., Shallis, R. M., Xie, Z., Kuykendall, A. T., Padron, E., Sweet, K., Walker, A. R., Komrokji, R. S., Lancet, J. E., Niyongere, S., Cluzeau, T., & Yun, S. (2026). Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents. Blood Cancer Discovery. https://doi.org/10.1158/2643-3230.bcd-25-0193
Source records
- crossref · retrieved 2026-11-04T06:59:46.510Z